Intensity Therapeutics, Inc. (INTS)
4.26
+0.01
(+0.24%)
USD |
NASDAQ |
Aug 31, 16:00
4.26
0.00 (0.00%)
After-Hours: 20:00
Intensity Therapeutics Market Cap : 12.55M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 12.52M |
| August 27, 2026 | 12.58M |
| August 26, 2026 | 13.34M |
| August 25, 2026 | 14.42M |
| August 24, 2026 | 13.99M |
| August 21, 2026 | 14.32M |
| August 20, 2026 | 14.37M |
| August 19, 2026 | 12.37M |
| August 18, 2026 | 12.40M |
| August 17, 2026 | 12.22M |
| August 14, 2026 | 11.66M |
| August 13, 2026 | 11.78M |
| August 12, 2026 | 12.25M |
| August 11, 2026 | 12.37M |
| August 10, 2026 | 12.64M |
| August 07, 2026 | 12.25M |
| August 06, 2026 | 12.52M |
| August 05, 2026 | 10.67M |
| August 04, 2026 | 10.62M |
| August 03, 2026 | 10.82M |
| July 31, 2026 | 10.54M |
| July 30, 2026 | 10.29M |
| July 29, 2026 | 11.00M |
| July 28, 2026 | 11.56M |
| July 27, 2026 | 11.61M |
| Date | Value |
|---|---|
| July 24, 2026 | 11.31M |
| July 23, 2026 | 11.25M |
| July 22, 2026 | 11.15M |
| July 21, 2026 | 11.18M |
| July 20, 2026 | 11.94M |
| July 17, 2026 | 12.07M |
| July 16, 2026 | 12.45M |
| July 15, 2026 | 12.30M |
| July 14, 2026 | 12.37M |
| July 13, 2026 | 12.50M |
| July 10, 2026 | 12.14M |
| July 09, 2026 | 12.47M |
| July 08, 2026 | 12.45M |
| July 07, 2026 | 12.14M |
| July 06, 2026 | 11.48M |
| July 02, 2026 | 10.77M |
| July 01, 2026 | 10.54M |
| June 30, 2026 | 10.42M |
| June 29, 2026 | 10.25M |
| June 26, 2026 | 10.42M |
| June 25, 2026 | 10.37M |
| June 24, 2026 | 10.37M |
| June 23, 2026 | 10.16M |
| June 22, 2026 | 9.997M |
| June 18, 2026 | 9.959M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.63B |
| Oncolytics Biotech, Inc. | 105.07M |
| Sangamo Therapeutics, Inc. | 66.49M |
| Sarepta Therapeutics, Inc. | 2.221B |
| Anixa Biosciences, Inc. | 114.15M |
Market Cap Related Metrics
| Price to Book Value | 1.362 |
| Price | 4.26 |
| Earnings Yield | -113.4% |